Healthcare Industry News: electrophysiology
News Release - May 12, 2011
Heart Force Medical Inc. Holds Clinical Advisory Board Meeting at HRS
VANCOUVER, BC, May 12, 2011 --(Healthcare Sales & Marketing Network)-- Heart Force Medical Inc., a Vancouver-based company that has developed a non-invasive cardiac assessment, monitoring and screening device is pleased to announce that it hosted its first Clinical Advisory Board meeting at the recent Heart Rhythm Society (HRS) conference held in San Francisco.The meeting was chaired by Dr. Frank Marcus of Heart Force’s clinical advisory board. In addition to Heart Force’s clinical advisors, several world prominent electrophysiologists participated in the meeting.
Heart Force presented recently compiled study data that demonstrated the non-invasive power of the dBG300. This presentation was received with a favourable response as it indicated the potential use of the dBG in cardiac resynchronization therapies.
Heart Force would like to congratulate Dr. Frank Marcus on the receipt of the Pioneer in Cardiac Pacing and electrophysiology Award at HRS. Dr. Marcus was recognized for his enormous scientific contributions to the field of cardiology and electrophysiology, having published more than 300 manuscripts.
“Having this group of prominent electrophysiologists provide Heart Force with feedback on our clinical plans allows us to drive towards commercial opportunities,” said Dr. Geoff Houlton, President, CEO and Chief Medical Officer of Heart Force Medical.
About Heart Force
Heart Force Medical Inc. (HFM), a private company, has invented and holds patents for the digital Ballistocardiograph (dBG™). The dBG 300, which is already approved in the United States, Europe and Canada, captures the movement of the heart during each cardiac cycle (heart beat). These movements (acceleration and force) are sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM’s proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.
For more information: visit www.heartforcemedical.com or contact:
Geoff Houlton, President, CEO, CMO
geoff.houlton@heartforcemedical.com
Direct: 604 566-8202
Issa Nakhleh, CFO
issa.nakhleh@heartforcemedical.com
Direct: 604 566-8206
Source: Heart Force Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!